Two Sigma Investments, LP Veru Inc. Transaction History

Two Sigma Investments, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.16 - $6.41 $919,397 - $5.08 Million	792,584 New	792,584 $919,000
Q2 2022 Aug 15, 2022	SELL	$4.35 - $15.85 $344,537 - $1.26 Million	-79,204 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $312,230 - $439,867	68,622 Added 648.48%	79,204 $383,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $875,919 - $1.45 Million	-148,713 Reduced 93.36%	10,582 $62,000
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $3.4 Million - $4.96 Million	-501,019 Reduced 75.88%	159,295 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $4.39 Million - $6.8 Million	606,718 Added 1132.02%	660,314 $5.33 Million
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $431,447 - $1.11 Million	53,596 New	53,596 $577,000
Q4 2020 Feb 16, 2021	SELL	$2.36 - $9.99 $64,871 - $274,605	-27,488 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.58 - $3.36 $312,105 - $406,462	-120,971 Reduced 81.48%	27,488 $72,000
Q2 2020 Aug 14, 2020	BUY	$3.01 - $4.02 $94,246 - $125,870	31,311 Added 26.73%	148,459 $496,000
Q1 2020 May 15, 2020	BUY	$2.58 - $4.58 $302,241 - $536,537	117,148 New	117,148 $383,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.